| Literature DB >> 28610574 |
Sarah B Hunter1, Bing Han2, Mary E Slaughter3, Susan H Godley4, Bryan R Garner5.
Abstract
BACKGROUND: Implementation support models are increasingly being used to enhance the delivery of evidence-based treatments (EBTs) in routine care settings. Little is known about the extent to which these models lead to continued EBT use after implementation support ends. Moreover, few empirical studies longitudinally examine the hypothesized factors associated with long-term psychosocial EBT use (i.e., sustainment). In an effort to address this gap, the current study examined sustainment of an EBT called the Adolescent-Community Reinforcement Approach (A-CRA) following the end of implementation support.Entities:
Keywords: Adolescent; Longitudinal analysis; Program sustainment; Substance use treatment
Mesh:
Year: 2017 PMID: 28610574 PMCID: PMC5470280 DOI: 10.1186/s13012-017-0606-8
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Ten core treatment elements of A-CRA sustainment
| Core A-CRA element | Source | Measurement | Scoring |
|---|---|---|---|
| 1. Clinical knowledge of A-CRA | Supervisor and clinician survey | 10 multiple-choice items that were derived from the A-CRA treatment manual which covered the theoretical underpinnings and the content of selected A-CRA procedures [ | Each item included five response options, and answers were coded as correct (scored as a “1”) or incorrect (scored as a “0”) for a total score range from 0 to 10. In organizations where more than one respondent delivered A-CRA, scores were averaged across respondents. |
| 2. A-CRA dosage | Clinician interview | One open-ended item that asked how many A-CRA treatment sessions clients were told that they would receive | If all clinicians at an organization endorsed a value within the treatment developers’ recommended range of sessions (i.e., 11–15 sessions), the organization received a score of “1;” otherwise, the organization scored “0”. |
| 3. Clinical staff penetration | Supervisor interview and verification with certification documentation | Supervisors were asked (a) how many clinicians were on staff in the adolescent substance use treatment program and (b) the number and name of those clinicians who were certified to deliver A-CRA | Responses were verified using the treatment developer records that documented who had successfully completed the certification process. Each organization received a score from 0 to 1 based on the proportion of clinicians in the youth treatment program that were certified to deliver A-CRA. |
| 4. Presence of certified A-CRA supervisor(s) | Supervisor interview and verification with certification documentation | Supervisors were asked whether their organization currently had any A-CRA-certified clinical supervisor(s) within their adolescent substance use treatment program | Responses were verified using the treatment developer records that documented who had successfully completed the supervision certification process. Each organization received a score of “1” for having an A-CRA-certified clinical supervisor on staff at the time of the interview or a “0” if no current staff were certified to provide A-CRA clinical supervision. |
| 5. Recommended frequency of clinical supervision | Clinician interview | Clinicians were asked how often they received clinical supervision. Bi-weekly clinical supervision is emphasized as part of the A-CRA training protocol [ | Organizations where clinicians reported receiving clinical supervision every 2 weeks or more were coded a “1” and organizations where clinicians reported receiving clinical supervision less frequently were coded a “0.” If more than one clinician responded per organization, the responses were averaged for an organization-level score. |
| 6. Recommended clinical supervision content | Clinician interview | Six items based on the rating manual used for coding-recorded supervision sessions during the supervision certification process [ | Responses to the six items were scored correct (coded as “1”) or incorrect (coded as “0”). Two items were weighted more due to their relative importance and the average proportion correct was used for a range of 0–1.5. If more than one clinician responded per organization, the responses were averaged for an organization-level score. |
| 7. Review and feedback on treatment sessions | Clinician interview | Clinicians were asked whether their clinical supervisor reviewed recorded treatment sessions and (a) told the clinician what they had done well and (b) gave suggestions about how the clinician could improve treatment delivery. These items were based on the guidelines in the A-CRA treatment manual. | Responses were scored “0” if clinicians reported that their clinical supervisors did not review sessions, “2” if the sessions were reviewed and clinicians were told they had done well, or “4” if session review also included suggestions on how treatment delivery could be improved. If more than one clinician responded per organization, the responses were averaged for an organization-level score. |
| 8. Clinical supervisors’ knowledge of A-CRA training and certification process | Supervisor interview | Supervisors who had reported training staff in the A-CRA model were asked 15 true or false statements about the certification process. These statements were drawn from a list of requirements of the A-CRA certification process and outlined in the A-CRA coding manual [ | Organizations where supervisor(s) correctly answered the recording question (i.e., the correct answer was 8 or more recordings) received a “1” and organizations where respondents incorrectly answered this question received a “0.” The score on the certification process questions and recordings question were combined by taking the average of these two measures to form the score on this element. In organizations with more than clinical supervisor, the percentage correct was averaged to create an organization-level value that ranged from 0 to 100%. |
| 9. On-site A-CRA training quality | Supervisor interview and documentation | Supervisors who reported providing A-CRA training at their organization were asked to submit a training agenda. Submission of a training agenda was one of the required elements for the A-CRA Clinical Supervisor Certification process and supervisors were provided feedback until their agendas met specified criteria | Submitted agendas were rated by a member of the A-CRA implementation support team for its coverage of key A-CRA training aspects. Scores ranged from 0 to 1 representing the proportion of A-CRA training aspects covered (e.g., inclusion of half of the training elements would be scored 0.5). |
| 10. Youth penetration | Supervisor interview | Supervisors were asked (a) how many youth clients had received substance use treatment at their organization in the past 6 months and (b) how many youth received A-CRA during that same period. | A proportion of youth clients receiving A-CRA (of those receiving any substance use treatment) was calculated for each organization (range 0–1). |
The number of participating organizations by the different funding mechanisms
| None | AAFT1 | AAFT2 | AAFT3 | AAFT4 | AAFT1 and AAFT3 | AAFT1 and AAFT4 | AAFT2 and AAFT3 | AAFT2 and AAFT4 | AAFT3 and AAFT4 | AAFT1, AAFT3, and AAFT4 | Totals | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JDC | 3 | 1 | 4 | |||||||||
| JTDC | 5 | 1 | 2 | 8 | ||||||||
| ORP | 6 | 1 | 7 | |||||||||
| TCE | 1 | 1 | 2 | |||||||||
| None | 4 | 15 | 6 | 23 | 3 | 4 | 1 | 1 | 57 | |||
| Totals | 15 | 6 | 15 | 6 | 23 | 3 | 4 | 1 | 1 | 3 | 1 | 78 |
“None” in the column means no funding from the AAFT initiatives; “None” in the row means no JDC, JTDC, ORP, or TCE initiatives
AAFT Assertive Adolescent Family Treatment, JDC Juvenile Drug Court, JDTC Juvenile Drug Treatment Court, ORP Offender Reentry Program, OJJDP Office of Juvenile Justice & Delinquency Prevention, TCE Targeted Capacity Expansion
Descriptive statistics of the 10 core A-CRA elements
| Element (range) | All | Mixture pattern ≦12 months | Mixture pattern >12 months | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| 1. Clinical knowledge of A-CRA (0–1) | 0.70 | 0.21 | 0.68 | 0.23 | 0.72 | 0.18 |
| 2. A-CRA dosage (0–1) | 0.44 | 0.50 | 0.33 | 0.49 | 0.50 | 0.51 |
| 3. Clinical staff penetration (0–1) | 0.35 | 0.40 | 0.22 | 0.37 | 0.49 | 0.38 |
| 4. Presence of certified A-CRA supervisor(s) (0–1) | 0.77 | 0.42 | 0.61 | 0.49 | 0.92 | 0.27 |
| 5. Recommended frequency of clinical supervision (0–1) | 0.57 | 0.50 | 0.71 | 0.46 | 0.45 | 0.51 |
| 6. Recommended clinical supervision content (0–1.5) | 1.06 | 0.34 | 1.11 | 0.39 | 1.02 | 0.30 |
| 7. Review and feedback on treatment sessions (0–4) | 2.12 | 1.97 | 2.71 | 1.86 | 1.70 | 1.98 |
| 8. Clinical supervisors’ knowledge of A-CRA training and certification process (0–1) | 0.30 | 0.33 | 0.24 | 0.31 | 0.36 | 0.34 |
| 9. On-site A-CRA training quality (0–1) | 0.15 | 0.24 | 0.00 | 0.00 | 0.15 | 0.24 |
| 10. Youth penetration (0–1) | 0.40 | 0.40 | 0.20 | 0.35 | 0.58 | 0.36 |
Descriptive statistics on the hypothesized factors and outcome by sustainment time
| Mixture pattern ≦12 months | Mixture pattern >12 months | |||
|---|---|---|---|---|
| ( | ( | |||
| Mean | SD | Mean | SD | |
| External setting | ||||
| Communications | 22.98 | 4.97 | 22.54 | 6.58 |
| Funding stability | 14.92 | 4.89 | 19.54 | 5.85 |
| Partnerships | 19.67 | 6.11 | 20.74 | 6.23 |
| Political support | 21.19 | 5.21 | 24.05 | 5.62 |
| Inner setting | ||||
| Clinician turnover rate | 0.37 | 0.41 | 0.36 | 0.85 |
| Implementation leadership | 46.75 | 8.82 | 50.47 | 4.60 |
| Organizational capacity | 24.61 | 6.61 | 25.14 | 5.60 |
| Strategic planning | 20.26 | 5.25 | 22.03 | 5.34 |
| ORC Scale: org climate | 36.40 | 4.35 | 37.85 | 2.48 |
| ORC Scale: staff attributes | 41.03 | 4.72 | 42.49 | 2.42 |
| Agency focus | 0.35 | 0.44 | 0.54 | 0.40 |
| No. of services offered | 12.00 | 2.77 | 12.81 | 2.08 |
| Client-staff ratio | 5.54 | 7.31 | 10.26 | 8.96 |
| Supervisor turnover rate | 0.48 | 0.77 | 0.24 | 0.45 |
| Implementation-related | ||||
| No. of clinicians certified/employed at grant end | 1.47 | 1.20 | 2.71 | 1.47 |
| No. of supervisors certified/employed at grant end | 0.84 | 0.72 | 1.00 | 0.77 |
| No. of youth served during grant period | 91.92 | 44.40 | 144.21 | 109.83 |
| Perceptions of the intervention | ||||
| Complexity | 7.21 | 2.32 | 5.84 | 1.59 |
| Implementation difficulty | 16.14 | 3.13 | 14.94 | 2.45 |
| Perceived success | 20.38 | 3.33 | 20.88 | 2.42 |
| Relative advantage | 15.90 | 2.97 | 16.61 | 1.79 |
| Outcome | ||||
| Sustainment score | 5.53 | 1.24 | 6.37 | 1.25 |
Results from the marginal regression analyses predicting the extent of sustainment
| Predictors | Estimate | SE |
|
|
|---|---|---|---|---|
| External setting | ||||
| Communications | 0.05 | 0.02 | 2.98 | 0.005* |
| Funding stability | 0.05 | 0.02 | 2.97 | 0.006* |
| Partnerships | 0.05 | 0.02 | 2.99 | 0.005* |
| Inner setting | ||||
| Clinician turnover rate | 0.43 | 0.53 | 0.81 | 0.425 |
| Implementation leadership | 0.01 | 0.01 | 1.23 | 0.226 |
| Organizational capacity | 0.07 | 0.02 | 4.39 | <0.001* |
| Political support | 0.06 | 0.02 | 3.16 | 0.003* |
| Strategic planning | 0.05 | 0.02 | 2.35 | 0.025* |
| ORC Scale: org climate | 0.04 | 0.02 | 1.67 | 0.106 |
| ORC Scale: staff attributes | 0.04 | 0.03 | 1.33 | 0.195 |
| Agency focus | −0.04 | 0.30 | −0.13 | 0.899 |
| No. of services offered | 0.03 | 0.06 | 0.44 | 0.666 |
| Client-staff ratio | 0.00 | 0.01 | 0.43 | 0.670 |
| Supervisor turnover rate | −1.21 | 0.35 | −3.46 | 0.003* |
| Implementation-related | ||||
| No. of clinicians certified/employed at grant end | 0.32 | 0.11 | 2.91 | 0.006* |
| No. of supervisors certified/employed at grant end | 0.55 | 0.20 | 2.73 | 0.010* |
| No. of youth served during grant period | 0.01 | 0.01 | 2.61 | 0.014* |
| Perceptions of the intervention | ||||
| Complexity | −0.04 | 0.07 | −0.63 | 0.536 |
| Implementation difficulty | −0.14 | 0.04 | −3.30 | 0.002* |
| Perceived success | 0.14 | 0.05 | 2.61 | 0.014* |
| Relative advantage | 0.17 | 0.06 | 3.03 | 0.005* |
*Statistically significant controlling for false discovery rate <0.05